Lawmakers call for more FDA oversight of compounded drugs 
By:
Kimberly Atkins
Published: May 24, 2013
Tags: Congress, drug compounds, Food and Drug Administration, fungal meningitis
WASHINGTON – After advancing two bills aimed at boosting the Food and Drug Administration’s regulatory authority over compounding drugs, Senate lawmakers released a report calling for a uniform statutory framework to better protect public health.
Company behind national fungal meningitis outbreak files for bankruptcy
Published: January 2, 2013
Tags: CDC, Centers for Disease Control and Prevention, fungal meningitis, meningitis litigation, NECC, New England Compounding Center
The medical compounding company behind the fungal meningitis outbreak and a defendant in numerous lawsuits has filed for bankruptcy.
As meningitis outbreak spreads, so do lawsuits
By:
Sylvia Hsieh
Published: November 26, 2012
Tags: Centers for Disease Control and Prevention, drug litigation, FDA, Food and Drug Administration, fungal meningitis, meningitis, NECC, New England Compounding Center, steroid injections, wrongful death
Lawsuits over the fungal meningitis outbreak from contaminated steroid injections are spreading nationwide as more cases are discovered.
